[Hypoglycemia after treatment with Glibenclamid (Euglucon 5)].
D000368:Aged; D001645:Biguanides / Q000627:therapeutic use; D003510:Cyclohexanes / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced* / Q000175:diagnosis; D007004:Hypoglycemic Agents / Q000009:adverse effects; D008297:Male; D010629:Phenformin / Q000627:therapeutic use; D013450:Sulfones / Q000009:adverse effects; D014508:Urea / Q000009:adverse effects*
D001645:Biguanides; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D013450:Sulfones; D014508:Urea; D010629:Phenformin
Hypoglykämien nach Behandlung mit Glibenclamid (Euglucon 5)